Amanote Research
Register
Sign In
Pmh3 - Comparing the Risk of Suicidality in Adult Versus Youth Patients Treated With Serotonin Reuptake Inhibitors - A Real-World Evidence-Based Approach
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.1640
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
S. Palm
Publisher
Elsevier BV
Related search
Selective Serotonin Reuptake Inhibitors and Operative Bleeding Risk
Journal of Clinical Psychopharmacology
Psychiatry
Mental Health
Pharmacology
Apathy Syndrome in a Patient Previously Treated With Selective Serotonin Reuptake Inhibitors for Depression
Yeungnam University Journal of Medicine
Selective Serotonin Reuptake Inhibitors.
BMJ
Antidepressant-Coincident Mania in Children and Adolescents Treated With Selective Serotonin Reuptake Inhibitors
Future Neurology
Neurology
Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors and Migraine: Should Cochrane Close the Door?
Journal of Biomedical Science and Engineering
Hyponatremia Associated With Selective Serotonin Reuptake Inhibitors
Internal Medicine
Internal Medicine
Medicine
Selective Serotonin Reuptake Inhibitors May Be Helpful in Most Patients With Stroke
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
Serotonin Noradrenaline Reuptake Inhibitors (SNRIs)
Selective Serotonin Reuptake Inhibitors Induced Serotonin Syndrome –A Case Report
International Journal of Hospital Pharmacy